Solid Tumor
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCI-97-C-0147, NCT00026884
Print this page 
Investigator(s): |
W. Marston Linehan, M.D.
Principal Investigator
Phone: 301-496-6353
linehanm@mail.nih.gov
|
|
|
|
|
|
|
| |
Key Eligibility Criteria:
- Suspected of having or with prior biopsy proof of malignant disease
- Patients must be able to provide informed consent
Study Outline:
- Selected patients suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI and at the National Naval Medical Center
- Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease; samples will be stored in the tissue bank of the Urologic Oncology Branch
- Samples of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank of the Urologic Oncology Branch
Additional Information:
- This trial will be conducted at the NIH Clinical Center in Bethesda, MD. It is open to patients who meet the eligibility requirements, regardless of where they live in the United States.
- There is no charge for medical care received at NIH Clinical Center.
- PDQ (Physicians Data Query) - provides additional details about this study for health care providers.
Reviewed: 12/14/12
Updated: 12/8/10
Back to Top
